International Clinical Trial: Neoadjuvant therapy with iparolituoworili combined with SOX chemotherapy regimen for locally advanced gastric/gastroesophageal junction adenocarcinoma: A prospective, multicenter, phase II, open-label, single-arm study

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115746) titled 'Neoadjuvant therapy with iparolituoworili combined with SOX chemotherapy regimen for locally advanced gastric/gastroesophageal junction adenocarcinoma: A prospective, multicenter, phase II, open-label, single-arm study' on Dec. 30, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Bengbu Medical University

Condition: Bengbu Medical University

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-30

Target Sample Size: Research group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org...